Neurana Pharmaceuticals
David Hale has been a director at Neurana Pharmaceuticals since 1997. Prior to that, they were the chairman and CEO of Gensia from 1987 to 1997. From 1982 to 1987, they were the president of Hybritech, Incorporated. David began their career in 1979 as a director of marketing for Johnson and Johnson.
This person is not in the org chart
This person is not in any offices
Neurana Pharmaceuticals
Neurana Pharmaceuticals is a privately-held clinical-stage San Diego-based specialty pharmaceutical company developing a novel treatment for acute muscle spasms. The Company was founded in 2013 to focus on central nervous system (CNS) diseases and disorders.